55 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
, process development, quality assurance/control development, statistical analysis, clinical studies, quality of life assessments, pharmacoeconomics, post … , quality control and assurance testing, in each case with respect to STS101, or (C) the promotion, sales, marketing, and distribution for sale of STS101
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
24 May 23
Tender offer solicitation (amended)
9:40pm
and provided assurance of the fairness of the Offer and the Merger to the Unaffiliated Stockholders.
The Independent Directors believe that by (i … that this thorough process provided assurance of the fairness of the Offer and the Merger to the Unaffiliated Stockholders, as none of the other
SC 14D9
i2yjqcp7r9n8mtqa
5 May 23
Tender offer solicitation
8:17am
10-K/A
EX-31.2
r8nrfs o4tny2y
28 Apr 23
Annual report (amended)
4:08pm
10-K/A
EX-31.1
j1ehjhoynjw
28 Apr 23
Annual report (amended)
4:08pm
8-K
EX-2.1
t8llgpx
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-10.1
3nzkli3v2eii s2
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
k8t 6h1v0i
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
lk7eb
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
8-K
EX-1.1
g6brtj yhe7a
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
qy04kerp5ypj24o8rsz7
3 Nov 22
Prospectus supplement for primary offering
4:42pm